Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | FAAH | O00519 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181056 | 1.00 | HTR1A (0.37) | HTR1ADRD3CYP1B1MGLLALDH1A1 | |
| Bicarbonate SCHEMBL9228837 | 0.94 | HTR1A (0.34) | HTR1ADRD3CYP1B1LMNA | |
| SCHEMBL485615 | 0.83 | MGLL (0.44) | CYP1B1MGLLALDH1A1FAAHLMNA | |
| SCHEMBL14348230 | 0.80 | CPB2 (0.33) | HTR1A | |
| SCHEMBL3800428 | 0.78 | PTGS1 (0.40) | MAPK1 | |
| SCHEMBL45794 | 0.78 | PTGS1 (0.33) | — | |
| SCHEMBL322605 | 0.77 | — | — | |
| SCHEMBL14788002 | 0.76 | ALOX12 (0.33) | HTR1ACYP1B1MGLLPOLB | |
| SCHEMBL20365061 | 0.75 | CYP1B1 (0.44) | CYP1B1MGLLALDH1A1FAAHLMNA | |
| SCHEMBL19725975 | 0.74 | BACE1 (0.33) | CYP1B1ALDH1A1BLMHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396373-A1 | SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION | Becton, Dickinson and Company (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396368-A1 | USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS | Becton, Dickinson and Company (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023034794-A1 | RNA PRESERVATION AND RECOVERY FROM FIXED CELLS | BECTON, DICKINSON AND COMPANY (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023034872-A1 | SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION | BECTON, DICKINSON AND COMPANY (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023034790-A1 | USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS | BECTON, DICKINSON AND COMPANY (US) | 2023-03-09 | — | — | WO | disclosed |
| EP-3612545-A1 | METHODS FOR IDENTIFYING COMPOUNDS | X-Chem, Inc. (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-3512856-A1 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | Polytherics Limited (GB) | 2019-07-24 | — | — | EP | disclosed |
| EP-3405208-A1 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATION | Tufts Medical Center, Inc. (US) | 2018-11-28 | — | — | EP | disclosed |
| WO-2018195134-A1 | METHODS FOR IDENTIFYING COMPOUNDS | X-CHEM, INC. (US) | 2018-10-25 | — | — | WO | disclosed |
| WO-2018051109-A1 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | POLYTHERICS LIMITED (GB) | 2018-03-22 | — | — | WO | disclosed |
| EP-1039834-A4 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-1146911-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001008660-A2 | TARGETED FIBERLESS RADIATIVE EFFECTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-1039834-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 2000-10-04 | — | — | EP | disclosed |
| EP-1037673-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-2000045856-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2000-08-10 | — | — | WO | disclosed |
| EP-0959908-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998042383-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | disclosed |